Google News


New Weight-Loss Drug Shows Promise in Trial - U.S. News & World Report


AFP
New Weight-Loss Drug Shows Promise in Trial
U.S. News & World Report
As it stands, Xenical is the only FDA-approved drug specifically for long-term use -- up to a year -- for weight loss. Xenical is sold over the counter as Alli. Other drugs, however, may be used off-label to promote weight loss.
US panel gives nod to new obesity drugTurkish Press
ARENA DIET PILL GETS PANEL'S OKU-T San Diego
Arena Soars After Weight-Loss Pill Wins Panel BackingBusinessWeek
Seeking Alpha -USA TODAY
all 653 news articles »

Continue Reading 05/11/2012

US panel gives nod to new obesity drug - Hindustan Times


Hindustan Times
US panel gives nod to new obesity drug
Hindustan Times
One drug, known as Xenical (Orlistat) by Roche and over the counter as Alli by GlaxoSmithKline, works by preventing the body from absorbing fat, though its tendency to cause gastrointestinal side effects such as oily, loose stools have curbed its ...
FDA panel recommends lorcaserin for obesityTheHeart.Org

all 16 news articles »

Continue Reading 05/15/2012

Obesity drugs vie for approval as FDA panel backs lorcaserin - InPharm


InPharm
Obesity drugs vie for approval as FDA panel backs lorcaserin
InPharm
Qnexa was backed by an FDA panel in February and now both drugs will hope to become the first anti-obesity treatment approved in the US since Roche's Xenical in 1999. Both drugs were rejected by the FDA two years ago after safety concerns, ...
FDA panel backs Arena weight-loss pill lorcaserinSan Francisco Chronicle
FDA Panel Recommends Lorcaserin for ObesityMedscape
Panel advises FDA to approve lorcaserin obesity pillCBS News
Yahoo! Philippines News -MSN Money -U-T San Diego
all 52 news articles »

Continue Reading 05/14/2012

Dr. Oz's Top 4 Appetite Suppressants Compared to Natural Suppressants for ... - eMaxHealth


eMaxHealth
Dr. Oz's Top 4 Appetite Suppressants Compared to Natural Suppressants for ...
eMaxHealth
One example of an effective drug on the weight loss market is Xenical (Orlistat). Xenical has been shown to be effective in weight loss through its mechanism of action as a fat blocker. Taking Xenical can block up to approximately 30% of the fat ...

and more »

Continue Reading 05/07/2012

Anti-Obesity Drugs a Hot Topic in the Biotech Industry - MarketWatch (press release)


Anti-Obesity Drugs a Hot Topic in the Biotech Industry
MarketWatch (press release)
Roche's Xenical was the last weight-loss drug approved by the FDA in 1999. Paragon Report provides Market Research focused on equities that offer growth opportunities, value, and strong potential return. We strive to provide the most up-to-date market ...

and more »

Continue Reading 05/14/2012

Vivus Pill Promising Faster-Than Viagra Erection Approved - Bloomberg


Bloomberg
Vivus Pill Promising Faster-Than Viagra Erection Approved
Bloomberg
Vivus is competing with Arena Pharmaceuticals Inc. (ARNA) and Orexigen Therapeutics Inc. (OREX) to bring the first weight-loss drug to market since Roche Holding AG's Xenical in 1999. FDA advisers voted Feb. 22 in favor of Vivus's Qnexa, while raising ...

and more »

Continue Reading 04/27/2012

Heart Drug Trials Ended By Roche - The Clare Herald


Heart Drug Trials Ended By Roche
The Clare Herald
... is disappointing for the patients and for the many people who have worked to prepare the Roche site for the production of Dalcetrapib, that the Clarecastle site works on a number of Roche medicines including CellCept, Xenical, Xeloda and Invirase.

and more »

Continue Reading 05/08/2012

Why dieting makes you fat: Research shows trying to lose weight alters your ... - Daily Mail


Daily Mail
Why dieting makes you fat: Research shows trying to lose weight alters your ...
Daily Mail
The only remaining prescription weight loss pill is Xenical, which prevents fat absorption. But at best you will lose 10lb a year and a known side-effect is faecal incontinence. But a new range of options is emerging. First among them is Qnexa, ...

and more »

Continue Reading 04/23/2012

Roche ends trials of heart drug Dalcetrapib - RTE.ie


Roche ends trials of heart drug Dalcetrapib
RTE.ie
... is disappointing for the patients and for the many people who have worked to prepare the Roche site for the production of Dalcetrapib, that the Clarecastle site works on a number of Roche medicines including CellCept, Xenical, Xeloda and Invirase.

and more »

Continue Reading 05/08/2012

UPDATED: Alli sale still held hostage by Roche GMP issues - FiercePharma Manufacturing


UPDATED: Alli sale still held hostage by Roche GMP issues
FiercePharma Manufacturing
Omega picked up GSK's manufacturing plant in Herrenberg, Germany, as part of that deal. In December, it sold its North American OTC products to Prestige Brands Holdings ($PBH) for $660 million. Alli is a lower-strength version of Roche's Xenical.

Continue Reading 04/24/2012


Sponsored Links